Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

Medications and Treatment Pathways for LGS

At a Glance

Lennox-Gastaut Syndrome (LGS) treatment focuses on reducing dangerous drop attacks using multiple medications simultaneously. First-line options typically include Valproate or Clobazam, while add-on therapies like Epidiolex, Rufinamide, or Fenfluramine are added to maximize safety and seizure control.

Treating Lennox-Gastaut Syndrome (LGS) is rarely about finding a “silver bullet.” Because the seizures are medically refractory (resistant to drugs), the goal of treatment is usually to reduce the frequency of the most dangerous seizures—especially drop attacks—to improve safety and quality of life [1][2]. Most patients require polypharmacy, which is the use of two or more medications at the same time [3][4].

First-Line Treatments

Expert consensus panels generally recommend starting with one of two foundational medications [4]:

  • Valproate (Depakote): Often the very first medication tried due to its broad-spectrum action against many seizure types. Warning: While highly effective, Valproate carries significant risks, including liver toxicity and severe birth defects (teratogenicity) if taken during pregnancy, requiring careful planning for young women [4][5].
  • Clobazam (Onfi): Frequently used as a first- or second-line treatment. It is highly effective for reducing atonic (limp) and tonic (stiffening) drop seizures [6][7].

Medications to Avoid

Because LGS is a generalized epilepsy, certain “narrow-spectrum” medications used for focal seizures—such as Carbamazepine, Oxcarbazepine, and Phenytoin—can actually worsen LGS seizures, particularly drop attacks and atypical absence [4].

Adjunctive (Add-on) Therapies

If first-line medications do not provide enough control, your doctor will likely add a second or third “adjunctive” medication.

For Drop Attacks (Atonic/Tonic Seizures)

  • Rufinamide (Banzel): Often a preferred second-line choice specifically for drop attacks [8][9]. It works differently than other medications and is often paired with Clobazam [8].
  • Cannabidiol (Epidiolex): A highly purified, plant-derived CBD that does not contain THC and does not cause a “high” [10]. It has shown consistent success in reducing the number of drop attacks [11].
  • Fenfluramine (Fintepla): Now FDA-approved for LGS. It can be very effective but requires monitoring for side effects like decreased appetite and weight loss [3][12].

Other Established Options

  • Lamotrigine (Lamictal) and Topiramate (Topamax): Both are well-established “add-on” options that have been shown to help with drop seizures [3].
  • Felbamate (Felbatol): An older but effective medication often reserved for when other treatments fail due to its need for intense monitoring of blood and liver function [3][4].

Managing “Drug-Drug” Interactions

Because LGS involves multiple medications, they often interact with each other in the body. This must be managed carefully:

  • The Epidiolex-Clobazam Interaction: When taken together, Epidiolex can slow down the breakdown of Clobazam. This increases the levels of Clobazam’s active metabolite (N-desmethylclobazam) in the blood [13][14]. While this can sometimes make the treatment more effective, it can also cause extreme sleepiness (somnolence) or sedation [13][15].
  • Liver Monitoring: If a patient is taking Valproate and Epidiolex together, there is an increased risk of elevated liver enzymes [5]. Regular blood tests are necessary.

Treatment Logic Table

Seizure Type Common “Go-To” Medications
Drop Attacks (Safety Priority) Clobazam, Rufinamide, Cannabidiol, Fenfluramine [3][9]
Tonic (Stiffening) Valproate, Clobazam, Rufinamide [4][8]
Atypical Absence (Staring) Valproate, Lamotrigine [4][3]

Always discuss the balance between seizure control and “daytime alertness” with your medical team. The best medication plan is the one that maximizes safety while maintaining quality of life.

Common questions in this guide

What are the first-line medications for LGS?
Doctors typically recommend starting with Valproate (Depakote) or Clobazam (Onfi). These broad-spectrum medications are effective against many seizure types associated with LGS, particularly stiffening or limp drop seizures.
Why do some epilepsy medications make LGS seizures worse?
Because LGS is a generalized epilepsy, narrow-spectrum medications like Carbamazepine, Oxcarbazepine, and Phenytoin can actually worsen drop attacks and atypical absence seizures. These are typically avoided in LGS treatment plans.
What are the best add-on medications for LGS drop attacks?
If first-line drugs aren't enough, doctors often add Rufinamide, Cannabidiol (Epidiolex), or Fenfluramine. These adjunctive therapies work differently than foundational medications and specifically help reduce the frequency of dangerous drop attacks.
Why does taking Epidiolex and Clobazam together cause severe sleepiness?
Epidiolex slows down how the body breaks down Clobazam, leading to higher levels of active medication in the blood. While this interaction can make treatment more effective, it often causes extreme sleepiness or sedation and requires careful monitoring.
How is treatment success measured for Lennox-Gastaut Syndrome?
Because LGS is typically resistant to medications, complete seizure freedom is rare. Instead, doctors focus on reducing the frequency of dangerous drop attacks to improve the patient's safety, daytime alertness, and overall quality of life.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are we monitoring the levels of the active metabolite (N-desmethylclobazam) to avoid excessive sedation given the current medication combination?
  2. 2.Given the frequency of drop attacks, would Rufinamide be an appropriate next step if our current first-line medications aren't working?
  3. 3.What is our target seizure reduction goal for Fenfluramine, and what specific side effects should we watch for?
  4. 4.Are there any medications currently being taken that might actually make LGS seizures worse?
  5. 5.How often should we be doing blood work to check liver function while on this combination of medications?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Lennox-Gastaut syndrome: a comprehensive review.

    Asadi-Pooya AA

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2018; (39(3)):403-414 doi:10.1007/s10072-017-3188-y.

    PMID: 29124439
  2. 2

    Understanding the Burden of Lennox-Gastaut Syndrome: Implications for Patients, Caregivers, and Society in High and Low Resource Settings: A Narrative Review.

    Mourid MR, Oduoye MO

    Health science reports 2024; (7(12)):e70169 doi:10.1002/hsr2.70169.

    PMID: 39669191
  3. 3

    Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.

    Besag FMC, Vasey MJ, Chin RFM

    Expert opinion on pharmacotherapy 2023; (24(11)):1249-1268 doi:10.1080/14656566.2023.2215924.

    PMID: 37212330
  4. 4

    Antiseizure medications for Lennox-Gastaut Syndrome: Comprehensive review and proposed consensus treatment algorithm.

    Samanta D, Bhalla S, Bhatia S, et al.

    Epilepsy & behavior : E&B 2025; (164()):110261 doi:10.1016/j.yebeh.2024.110261.

    PMID: 39854828
  5. 5

    Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.

    Sekar K, Pack A

    F1000Research 2019; (8()) doi:10.12688/f1000research.16515.1.

    PMID: 30854190
  6. 6

    Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome.

    Faulkner MA

    Therapeutics and clinical risk management 2015; (11()):905-14 doi:10.2147/TCRM.S55930.

    PMID: 26089675
  7. 7

    Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.

    Gunning B, Mazurkiewicz-Bełdzińska M, Chin RFM, et al.

    Acta neurologica Scandinavica 2021; (143(2)):154-163 doi:10.1111/ane.13351.

    PMID: 32969022
  8. 8

    Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.

    Sankar R, Chez M, Pina-Garza JE, et al.

    Seizure 2023; (110()):42-57 doi:10.1016/j.seizure.2023.05.018.

    PMID: 37321047
  9. 9

    Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.

    Striano P, McMurray R, Santamarina E, Falip M

    Epileptic disorders : international epilepsy journal with videotape 2018; (20(1)):13-29 doi:10.1684/epd.2017.0950.

    PMID: 29313492
  10. 10

    Unraveling Lennox-Gastaut Syndrome: From Molecular Pathogenesis to Precision Diagnosis and Targeted Therapy Evolving Therapeutic Strategies.

    Na JH, Lee YM

    International journal of molecular sciences 2026; (27(3)) doi:10.3390/ijms27031382.

    PMID: 41683806
  11. 11

    Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.

    Devinsky O, Patel AD, Cross JH, et al.

    The New England journal of medicine 2018; (378(20)):1888-1897 doi:10.1056/NEJMoa1714631.

    PMID: 29768152
  12. 12

    Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis.

    Tabaee Damavandi P, Fabin N, Giossi R, et al.

    Neurology and therapy 2023; (12(2)):669-686 doi:10.1007/s40120-023-00452-1.

    PMID: 36853503
  13. 13

    Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.

    Bergmann KR, Broekhuizen K, Groeneveld GJ

    British journal of clinical pharmacology 2020; (86(2)):380-385 doi:10.1111/bcp.14158.

    PMID: 31657863
  14. 14

    Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.

    Devinsky O, Thiele EA, Wright S, et al.

    Acta neurologica Scandinavica 2020; (142(6)):531-540 doi:10.1111/ane.13305.

    PMID: 32592183
  15. 15

    Interactions between cannabidiol and commonly used antiepileptic drugs.

    Gaston TE, Bebin EM, Cutter GR, et al.

    Epilepsia 2017; (58(9)):1586-1592 doi:10.1111/epi.13852.

    PMID: 28782097

This page provides educational information about Lennox-Gastaut Syndrome (LGS) medications. Always consult your neurologist or epileptologist before modifying your seizure medication regimen.

Get notified when new evidence is published on Lennox-Gastaut syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.